I Hellström1, K E Hellström, P D Senter. Show Affiliations » 1. Pacific Northwest Research Institute, Seattle, WA, USA.
Abstract
Entities: Chemical
Mesh： See more » AnimalsAntibiotics, Antineoplastic/administration & dosageAntibiotics, Antineoplastic/adverse effectsAntibiotics, Antineoplastic/chemistryAntibiotics, Antineoplastic/pharmacologyAntibiotics, Antineoplastic/therapeutic useAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/chemistryAntibodies, Monoclonal/immunologyAntibodies, Monoclonal/pharmacologyAntibodies, Monoclonal/therapeutic useAntigens, Neoplasm/immunologyCarcinoma/drug therapyCarcinoma/immunologyClinical Trials, Phase I as TopicColonic Neoplasms/drug therapyDaunorubicin/chemistryDaunorubicin/pharmacologyDigestive System/immunologyDoxorubicin/adverse effectsDoxorubicin/chemistryDoxorubicin/immunologyDoxorubicin/pharmacologyDoxorubicin/therapeutic useDrug DesignGastrointestinal Diseases/chemically inducedHumansImmunotoxins/adverse effectsImmunotoxins/chemistryImmunotoxins/pharmacologyImmunotoxins/therapeutic useLewis Blood Group Antigens/immunologyMiceMice, NudeNeoplasms/drug therapyNeoplasms, Experimental/drug therapyOrgan SpecificityRatsRats, Inbred BNRats, NudeTreatment FailureXenograft Model Antitumor Assays
Substances： See more » Antibiotics, AntineoplasticAntibodies, MonoclonalAntigens, NeoplasmBR96-doxorubicin immunoconjugateImmunotoxinsLewis Blood Group AntigensLewis Y antigenDoxorubicinDaunorubicin
Year: 2001 PMID： 11217374 DOI： 10.1385/1-59259-114-0:3
Source DB: PubMed Journal: Methods Mol Biol ISSN： 1064-3745